Trial Profile
MULTICENTER CLINICAL TRIAL TO DETERMINE THE INFLUENCE OF TREATMENT WITH DIRECT ANTIVIRAL AGENTS IN THE GLOMERULAR AND TUBULAR FUNCTION OF PATIENTS WITH CHRONIC HCV HEPATITIS
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 26 Sep 2018
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary) ; Sofosbuvir (Primary) ; Daclatasvir; Elbasvir/grazoprevir; Ombitasvir/paritaprevir/ritonavir; Simeprevir
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms RENAL-AAD
- 20 Sep 2018 Status changed from recruiting to discontinued.
- 24 May 2017 New trial record